| |
 |
|
Class Information
Number: 514/4
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Insulin or derivative > With an additional active ingredient
Description: Subject matter which contains insulin and an additional active ingredient.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5681587 |
Growth of adult pancreatic islet cells |
Oct. 28, 1997 |
| 5672581 |
Method of administration of insulin |
Sep. 30, 1997 |
| 5665700 |
Pharmaceutical formulations |
Sep. 9, 1997 |
| 5656590 |
Treatment of anorexia and related states |
Aug. 12, 1997 |
| 5641744 |
Treatment of diabetes mellitus |
Jun. 24, 1997 |
| 5624903 |
Phosphoinositol-glycan-peptide with insulin-like action |
Apr. 29, 1997 |
| 5622934 |
Peptides with an insulin-like action |
Apr. 22, 1997 |
| 5597802 |
Method of formulating IGF-I with growth hormone |
Jan. 28, 1997 |
| 5591713 |
Water-soluble composition for sustained-release |
Jan. 7, 1997 |
| 5591709 |
Compositions and methods for treating wounds |
Jan. 7, 1997 |
| 5589173 |
Method and therapeutic compositions for the treatment of myocardial infarction |
Dec. 31, 1996 |
| 5583114 |
Adhesive sealant composition |
Dec. 10, 1996 |
| 5561110 |
Method for the treatment of the complications and pathology of diabetes |
Oct. 1, 1996 |
| 5559094 |
Asp.sup.B1 insulin analogs |
Sep. 24, 1996 |
| 5547929 |
Insulin analog formulations |
Aug. 20, 1996 |
| 5547930 |
Asp.sup.B28 insulin crystals |
Aug. 20, 1996 |
| 5534488 |
Insulin formulation |
Jul. 9, 1996 |
| 5532129 |
Self-organizing molecular photonic structures based on chromophore- and fluorophore-containing polynucleotides and methods of their use |
Jul. 2, 1996 |
| 5518998 |
Therapeutic preparation for inhalation |
May. 21, 1996 |
| 5514646 |
Insulin analogs modified at position 29 of the B chain |
May. 7, 1996 |
| 5508260 |
Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
Apr. 16, 1996 |
| 5506203 |
Systemic administration of a therapeutic preparation |
Apr. 9, 1996 |
| 5496803 |
Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia in vertebrates |
Mar. 5, 1996 |
| 5482706 |
Transmucosal therapeutic composition |
Jan. 9, 1996 |
| 5474978 |
Insulin analog formulations |
Dec. 12, 1995 |
| 5461031 |
Monomeric insulin analog formulations |
Oct. 24, 1995 |
| 5461030 |
Compositions and methods for enhancing wound healing |
Oct. 24, 1995 |
| 5449522 |
Pharmaceutical composition for immunoenhancement therapy |
Sep. 12, 1995 |
| 5438040 |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
Aug. 1, 1995 |
| 5430016 |
Insulin compounds and compositions |
Jul. 4, 1995 |
| 5428023 |
Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof |
Jun. 27, 1995 |
| 5428006 |
Method of administering a biologically active substance |
Jun. 27, 1995 |
| 5422339 |
Peptides having insulin autoantibody but not insulin receptor binding capacity |
Jun. 6, 1995 |
| 5420108 |
Method of controlling diabetes mellitus |
May. 30, 1995 |
| 5405877 |
Cyclic imide thione activated polyalkylene oxides |
Apr. 11, 1995 |
| 5405831 |
Treatment of bone disorders |
Apr. 11, 1995 |
| 5397771 |
Pharmaceutical preparation |
Mar. 14, 1995 |
| 5382574 |
Insulin preparations containing nicotinic acid or nicotinamide |
Jan. 17, 1995 |
| 5374620 |
Growth-promoting composition and its use |
Dec. 20, 1994 |
| 5374616 |
Compositions containing sphingosylphosphorylcholine and the use thereof as a cellular growth factor |
Dec. 20, 1994 |
| 5368853 |
Leukoregulin anti-viral therapy |
Nov. 29, 1994 |
| 5364838 |
Method of administration of insulin |
Nov. 15, 1994 |
| 5364841 |
Treatment of obesity and essential hypertension and related disorders |
Nov. 15, 1994 |
| 5352666 |
Antiglaucoma compositions and methods |
Oct. 4, 1994 |
| 5321008 |
Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
Jun. 14, 1994 |
| 5321009 |
Method of treating diabetes |
Jun. 14, 1994 |
| 5321095 |
Azlactone activated polyalkylene oxides |
Jun. 14, 1994 |
| 5315998 |
Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same |
May. 31, 1994 |
| 5281582 |
Serum growth factor |
Jan. 25, 1994 |
| 5280014 |
Treatment of obesity and essential hypertension and related disorders |
Jan. 18, 1994 |
|
|
|
